Thus, the objective of this study was to capture and analyze studies that used orexin-A in humans for the treatment of narcolepsy type 1 and to elucidate its efficacy in the treatment of narcolepsy type 1. This evidence concerns the gene HCRT and narcolepsy-cataplexy syndrome.